Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
BMC Urology
|
November 1, 2022
The targets of aspirin in bladder cancer: bioinformatics analysis
Xiao Li, Yanghao Tai, Shuying Liu, et al.
Frontiers in Pharmacology
|
November 1, 2021
An <i>In-Silico</i>, <i>In-Vitro</i> and <i>In-Vivo</i> Combined Approach to Identify NMNATs as Potential Protein Targets of ProEGCG for Treatment of Endometriosis
Sze Wan Hung, Bo Liang, Yating Gao, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2022
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug <i>Potentilla discolor</i> Bunge
Longshan Ji, Qian Li, Yong He, et al.
Journal of Virus Eradication
|
October 27, 2025
Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failure
Yu Liu, Miao Fang, Hongying Guo, et al.
British Journal of Cancer
|
April 6, 2026
Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitors
Yue Huang, Yiling Xi, Huizong Nie, et al.
Journal of Ethnopharmacology
|
April 15, 2024
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Frontiers in Immunology
|
August 9, 2021
Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
Ying He, Sze Wan Hung, Bo Liang, et al.
Frontiers in Immunology
|
December 10, 2025
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
Ying He, Sze Wan Hung, Bo Liang, et al.
Heliyon
|
November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
Rongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Frontiers in Pharmacology
|
January 30, 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications
Yu Liu, Wei Yuan, Miao Fang, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
BMC Urology
|
November 1, 2022
The targets of aspirin in bladder cancer: bioinformatics analysis
Xiao Li, Yanghao Tai, Shuying Liu, et al.
Frontiers in Pharmacology
|
November 1, 2021
An <i>In-Silico</i>, <i>In-Vitro</i> and <i>In-Vivo</i> Combined Approach to Identify NMNATs as Potential Protein Targets of ProEGCG for Treatment of Endometriosis
Sze Wan Hung, Bo Liang, Yating Gao, et al.
Acta Pharmaceutica Sinica. B
|
September 30, 2022
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug <i>Potentilla discolor</i> Bunge
Longshan Ji, Qian Li, Yong He, et al.
Journal of Virus Eradication
|
October 27, 2025
Serum osteopontin levels predict short-term outcomes in patients with hepatitis B-related acute-on-chronic liver failure
Yu Liu, Miao Fang, Hongying Guo, et al.
British Journal of Cancer
|
April 6, 2026
Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitors
Yue Huang, Yiling Xi, Huizong Nie, et al.
Journal of Ethnopharmacology
|
April 15, 2024
Ba-Qi-Rougan formula alleviates hepatic fibrosis by suppressing hepatic stellate cell activation via the MSMP/CCR2/PI3K pathway
Yan Xue, Wanchun Zhu, Fengjie Qiao, et al.
Frontiers in Immunology
|
August 9, 2021
Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
Ying He, Sze Wan Hung, Bo Liang, et al.
Frontiers in Immunology
|
December 10, 2025
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
Ying He, Sze Wan Hung, Bo Liang, et al.
Heliyon
|
November 30, 2023
Integrating bulk and single-cell RNA sequencing data to establish necroptosis-related lncRNA risk model and analyze the immune microenvironment in hepatocellular carcinoma
Rongjie Zhang, Qian Li, Xiaoxiao Yu, et al.
Frontiers in Pharmacology
|
January 30, 2023
Determination of HMGB1 in hepatitis B virus-related acute-on-chronic liver failure patients with acute kidney injury: Early prediction and prognostic implications
Yu Liu, Wei Yuan, Miao Fang, et al.
Page
of 10